The Treatment of Schistosomiasis Mansoni in Murang'a District, Kenya: A Double Blind Controlled Trial of Three Hycanthone Regimens and Oxamniquine
American Journal of Tropical Medicine and HygienePublished 1 September 1975
Philip Rees, H. N. Bowry, Jacquelin M. Roberts, J. J. Thuku
Citations5
SJR quartileQ2
SJR score0.73
SNIP0.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
In a pilot study designed to find the most suitable drug regimen for the mass treatment of schistosomiasis mansoni, four regimens were found equally effective and hycanthone 1.5 mg/kg body weight in a single dose was thought to be the most satisfactory regimen.
Abstract
"The Treatment of Schistosomiasis Mansoni in Murang'a District, Kenya: A Double Blind Controlled Trial of Three Hycanthone Regimens and Oxamniquine" published on Sep 1975 by The American Society of Tropical Medicine and Hygiene.
Keywords
Immunology and Microbiology